T1	Participants 34 73	patients operated on for hip prosthesis
T2	Participants 598 730	211 patients of both sexes candidates to receive total hip arthroplasty and presenting at least one major thromboembolic risk factor
T3	Participants 2191 2236	patients undergoing major orthopaedic surgery
